BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12745955)

  • 1. Impairment, disability, and life satisfaction in Parkinson's disease.
    Dural A; Atay MB; Akbostanci C; Kucukdeveci A
    Disabil Rehabil; 2003 Apr; 25(7):318-23. PubMed ID: 12745955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of motor impairment influences quality of life in Parkinson's disease.
    Stewart KC; Fernandez HH; Okun MS; Jacobson CE; Hass CJ
    Mov Disord; 2008 Jul; 23(10):1466-8. PubMed ID: 18546324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinically important difference on the unified Parkinson's disease rating scale.
    Shulman LM; Gruber-Baldini AL; Anderson KE; Fishman PS; Reich SG; Weiner WJ
    Arch Neurol; 2010 Jan; 67(1):64-70. PubMed ID: 20065131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor structure of the Unified Parkinson's Disease Rating Scale: Motor Examination section.
    Stebbins GT; Goetz CG
    Mov Disord; 1998 Jul; 13(4):633-6. PubMed ID: 9686766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of motor impairment and disability in Parkinson disease: a population-based study.
    Alves G; Wentzel-Larsen T; Aarsland D; Larsen JP
    Neurology; 2005 Nov; 65(9):1436-41. PubMed ID: 16275832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Exercices program and rehabilitation of motor disorders in Parkinson's disease].
    Pélissier J; Pérennou D
    Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():190-200. PubMed ID: 10916050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationships between the unified Parkinson's disease rating scale and lower extremity functional performance in persons with early-stage Parkinson's disease.
    Song J; Fisher BE; Petzinger G; Wu A; Gordon J; Salem GJ
    Neurorehabil Neural Repair; 2009 Sep; 23(7):657-61. PubMed ID: 19336530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Depressive symptoms and motor condition in Parkinson's disease patients].
    Stella F; Bucken-Gobbi LT; Gobbi S; Sant'Ana-Simões C
    Rev Neurol; 2007 Nov 16-30; 45(10):594-8. PubMed ID: 18008264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the Unified Parkinson's Disease Rating Scale and of the Short Parkinson's Evaluation Scale.
    Martignoni E; Franchignoni F; Pasetti C; Ferriero G; Picco D
    Neurol Sci; 2003 Oct; 24(3):190-1. PubMed ID: 14598081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease.
    Weisscher N; Post B; de Haan RJ; Glas CA; Speelman JD; Vermeulen M
    Neurology; 2007 Dec; 69(23):2155-61. PubMed ID: 18056579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of idiopathic Parkinson's disease in physical medicine and rehabilitation].
    Pelissier J; Benaim C; Bonin-Koang KY; Castelnovo G; Perennou D
    Ann Readapt Med Phys; 2005 Jul; 48(6):341-5. PubMed ID: 15932779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of tremor and bradykinesia in Parkinson's disease using a novel ambulatory monitoring system.
    Salarian A; Russmann H; Wider C; Burkhard PR; Vingerhoets FJ; Aminian K
    IEEE Trans Biomed Eng; 2007 Feb; 54(2):313-22. PubMed ID: 17278588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High intensity eccentric resistance training decreases bradykinesia and improves Quality Of Life in persons with Parkinson's disease: a preliminary study.
    Dibble LE; Hale TF; Marcus RL; Gerber JP; LaStayo PC
    Parkinsonism Relat Disord; 2009 Dec; 15(10):752-7. PubMed ID: 19497777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
    Grosset KA; Grosset DG
    Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral subthalamic nucleus stimulation for Parkinson's disease.
    Doshi PK; Chhaya NA; Bhatt MA
    Neurol India; 2003 Mar; 51(1):43-8. PubMed ID: 12865514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH; Klasser M; Reichmann H
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of the trunk impairment scale as a measure of trunk performance in people with Parkinson's disease.
    Verheyden G; Willems AM; Ooms L; Nieuwboer A
    Arch Phys Med Rehabil; 2007 Oct; 88(10):1304-8. PubMed ID: 17908573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.
    Ramaker C; Marinus J; Stiggelbout AM; Van Hilten BJ
    Mov Disord; 2002 Sep; 17(5):867-76. PubMed ID: 12360535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of disability and quality of life in mild to moderate Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B; de Haan RJ;
    Neurology; 2008 Jun; 70(23):2241-7. PubMed ID: 18519873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.